RxDoctor Payments Data

Albert Rogers, MD

Clinical Cardiac Electrophysiology · Stanford, CANPI 1316365133

Payments from drug & device makers

$63,776in general payments, 2019–2025

Across 229 payments — averaging $278.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$17K
  • Boston Scientific$15K
  • Medtronic$13K
  • Atricure, Inc.$13K
  • Impulse Dynamics (USA) Inc.$3K
  • Biosense Webster, Inc.$2K
  • plus $614 from 2 others

What the payments were for

  • Consulting fees$9,38515%
  • Grants$22,95036%
  • Travel & lodging$21,02833%
  • Food & beverage$9,96916%
  • Education$4441%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott65$17,064
Boston Scientific23$15,309
Medtronic(2 entities)53$13,359
Atricure, Inc.11$12,520
Impulse Dynamics (USA) Inc.2$2,756
Biosense Webster, Inc.68$2,155
Biotronik Inc.6$600
KCI USA, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,776 in reported general payments places this provider in the 60th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$172,736
Medicare patients
1,964
Services billed
2,837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban95$109,075
XareltoRivaroxaban12$12,019
Dofetilide18$2,390
Flecainide Acetate44$1,312
Amiodarone Hcl34$797
Metoprolol Succinate46$720
Metoprolol Tartrate45$431
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$375
Pantoprazole Sodium45$254
Atorvastatin Calcium12$95

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →